|

BL-M11D1 Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 1: 2

Top Sponsors

  • SystImmune Inc.1
  • Sichuan Baili Pharmaceutical Co., Ltd.1

Indications

  • Cancer2
  • Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)1
  • Relapsed/Refractory Acute Myeloid Leukemia1

Other1 trial

A Study of BL-M11D1 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Phase 1

Duarte, California1 trial

Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1

City of Hope

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.